EUVIMEDEUVIMED entdecken
Crossref

In silico pathway-based subtractive proteomics for identifying novel drug targets in Candida albicans with structure-guided drug repurposing of aspartate-semialdehyde dehydrogenase inhibitors

Nithyashree Sriram, Suhadha Parveen Sadiq, Ravikumar Vilwanathan, Thirunavukkarasu Sivaraman, Muthukumar Govindhapriya, Ravi Kumar Trivedi, Muthusamy Sureshan

Journal of Molecular Modeling · 2026

DOI: 10.1007/s00894-026-06962-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Modeling, 2026. Verfasst von Nithyashree Sriram und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, The University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Candida albicans, Proteomics, Antifungal Agents, Aspartate-Semialdehyde Dehydrogenase. Die Arbeit nennt 150 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CONTEXT: Candida albicans is the most common cause of candidemia and is classified as a high-priority pathogen due to its increasing prevalence among fragilised and hospital-based patients. In this study, the subtractive proteomics approach identified 12 key targets involved in vital pathways that play a crucial role in metabolism and regulation, supporting fungal growth, maintaining balance, and enabling pathogenicity. These pathways are essential for the pathogen's survival and virulence, highlighting them as potential targets for treatments against C. albicans infections. Notably, aspartate-semialdehyde dehydrogenase (ASADH) plays a role in cell wall construction, stress-associated dormancy, and the production of virulence-associated components, which are critical aspects of C. albicans infections. The structure-guided virtual screening identified five potent hits: Acarbose, Iotrolan, Iodixanol, Nystatin, and Ferric derisomaltose, which exhibit better affinity, ranging from -12.25 to -11.90 kcal/mol with CaASADH and exhibits stable binding during 500 ns MD simulations, highlighting their potential as lead compounds for anti-C. albicans drug development. METHODS: Subtractive proteomics pipeline was performed in a standalone Linux environment, and the three-stage Schrödinger's Glide docking algorithm was used for molecular docking studies. All MD simulations were conducted using GROMACS for 500 ns, and the conformational dynamic stability was examined using RMSD, RMSF, Rg, SASA, PCA, CD-HIT, BLASTp, DrugBank, BlastKOALA, screening, SiteMap, LigPrep, SwissParam, MMPBSA, and CHARMM36 force field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida albicansProteomicsAntifungal AgentsAspartate-Semialdehyde DehydrogenaseDrug RepositioningEnzyme InhibitorsFungal ProteinsMolecular Docking SimulationMolecular Dynamics SimulationComputer Simulation

Stichwörter der Autor:innen

Candida albicansAntifungal resistanceAspartate-semialdehyde dehydrogenaseMD simulationMolecular dockingSubtractive proteomics

Substanzen

Antifungal AgentsAspartate-Semialdehyde DehydrogenaseEnzyme InhibitorsFungal Proteins

Autor:innen und Institutionen

  • School of Biological Sciences, The University of Auckland, Auckland, New Zealand.
  • Cancer Biology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.
  • Department of Chemistry, V.S.B. Engineering College, Karur, Tamil Nadu, 639111, India.
  • Department of Bioinformatics, School of Chemical & Biotechnology, SASTRA Deemed University, Thanjavur, 613401, India.
  • Department of Physics, Manipal University Jaipur, Jaipur, Rajasthan, 303007, India. ravi.trivedi@jaipur.manipal.edu.
  • Centre for Computational Physics, Karpagam Academy of Higher Education, Coimbatore, 641021, India. sureshan.tnj@gmail.com.

Zitieren

APA

Sriram, N., Sadiq, S. P., Vilwanathan, R., Sivaraman, T., Govindhapriya, M., Trivedi, R. K., & Sureshan, M. (2026). In silico pathway-based subtractive proteomics for identifying novel drug targets in Candida albicans with structure-guided drug repurposing of aspartate-semialdehyde dehydrogenase inhibitors. Journal of Molecular Modeling. https://doi.org/10.1007/s00894-026-06962-7

Vancouver

Sriram N, Sadiq SP, Vilwanathan R, Sivaraman T, Govindhapriya M, Trivedi RK, et al. In silico pathway-based subtractive proteomics for identifying novel drug targets in Candida albicans with structure-guided drug repurposing of aspartate-semialdehyde dehydrogenase inhibitors. Journal of Molecular Modeling. 2026. doi:10.1007/s00894-026-06962-7

BibTeX
@article{Sriram2026,
  author = {Sriram, Nithyashree and Sadiq, Suhadha Parveen and Vilwanathan, Ravikumar and Sivaraman, Thirunavukkarasu and Govindhapriya, Muthukumar and Trivedi, Ravi Kumar and Sureshan, Muthusamy},
  title = {In silico pathway-based subtractive proteomics for identifying novel drug targets in Candida albicans with structure-guided drug repurposing of aspartate-semialdehyde dehydrogenase inhibitors},
  journal = {Journal of Molecular Modeling},
  year = {2026},
  doi = {10.1007/s00894-026-06962-7}
}
Kostenlos starten →